Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2021Therapeutic Advances in Infectious DiseaseOpen Access

Prevention and management of carbapenem-resistant Enterobacteriaceae in haematopoietic cell transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

DSDangudubiyyam Sri Krishna SahityaAJAditya JandiyalAJArihant Jain

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sahitya et al. (2021) studied this question.

synapsesocial.com/papers/69d849018c03fbaff8beeb6dhttps://doi.org/10.1177/20499361211053480
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America2011 · 716 citations
  2. 2Outcomes of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Infection and the Impact of Antimicrobial and Adjunctive Therapies2008 · 841 citations
  3. 3Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae2018 · 711 citations
  4. 4Updated Functional Classification of β-Lactamases2009 · 2,354 citations
  5. 5Carbapenemases: the Versatile β-Lactamases2007 · 2,516 citations